Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120
- PMID: 11591348
- DOI: 10.1016/s0969-2126(01)00653-0
Solution structure of a cyanovirin-N:Man alpha 1-2Man alpha complex: structural basis for high-affinity carbohydrate-mediated binding to gp120
Abstract
Background: Cyanovirin-N (CVN) is a novel, 11 kDa cyanobacterial protein that potently inhibits viral entry by diverse strains of HIV through high-affinity carbohydrate-mediated interactions with the viral envelope glycoprotein gp120. CVN contains two symmetry-related carbohydrate binding sites of differing affinities that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinities, the carbohydrates that also mediate CVN:gp120 binding. High-resolution structural studies of CVN in complex with a representative oligosaccharide are desirable for understanding the structural basis for this unprecedented specificity.
Results: We have determined by multidimensional heteronuclear NMR spectroscopy the three-dimensional solution structure of CVN in complex with two equivalents of the disaccharide Manalpha1-2Manalpha, a high-affinity ligand which represents the terminal-accessible disaccharide present in Man(8) D1D3 and Man(9). The structure reveals that the bound disaccharide adopts the stacked conformation, thereby explaining the selectivity for Man(8) D1D3 and Man(9) over other oligomannose structures, and presents two novel carbohydrate binding sites that account for the differing affinities of the two sites. The high-affinity site comprises a deep pocket that nearly envelops the disaccharide, while the lower-affinity site comprises a semicircular cleft that partially surrounds the disaccharide. The approximately 40 A spacing of the two binding sites provides a simple model for CVN:gp120 binding.
Conclusions: The CVN:Manalpha1-2Manalpha complex provides the first high-resolution structure of a mannose-specific protein-carbohydrate complex with nanomolar affinity and presents a new carbohydrate binding motif, as well as a new class of carbohydrate binding protein, that facilitates divalent binding via a monomeric protein.
Similar articles
-
The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man(8) D1D3 and Man(9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120.J Am Chem Soc. 2001 May 2;123(17):3892-902. doi: 10.1021/ja004040e. J Am Chem Soc. 2001. PMID: 11457139
-
Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.J Mol Biol. 2002 Apr 19;318(1):1-8. doi: 10.1016/S0022-2836(02)00045-1. J Mol Biol. 2002. PMID: 12054763
-
Site-specific discrimination by cyanovirin-N for alpha-linked trisaccharides comprising the three arms of Man(8) and Man(9).J Mol Biol. 2002 Sep 27;322(4):881-9. doi: 10.1016/s0022-2836(02)00842-2. J Mol Biol. 2002. PMID: 12270721
-
Cyanovirin-N: a sugar-binding antiviral protein with a new twist.Cell Mol Life Sci. 2003 Feb;60(2):277-87. doi: 10.1007/s000180300023. Cell Mol Life Sci. 2003. PMID: 12678493 Free PMC article. Review.
-
Properties of cyanovirin-N (CV-N): inactivation of HIV-1 by sessile cyanovirin-N (sCV-N).Dev Biol (Basel). 2000;102:141-8. Dev Biol (Basel). 2000. PMID: 10794101 Review.
Cited by
-
HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth.Expert Opin Ther Targets. 2015 Jun;19(6):765-83. doi: 10.1517/14728222.2015.1010513. Epub 2015 Feb 27. Expert Opin Ther Targets. 2015. PMID: 25724219 Free PMC article. Review.
-
The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.J Virol. 2002 Jul;76(14):7293-305. doi: 10.1128/jvi.76.14.7293-7305.2002. J Virol. 2002. PMID: 12072528 Free PMC article.
-
Solution and crystal molecular dynamics simulation study of m4-cyanovirin-N mutants complexed with di-mannose.Biophys J. 2009 Nov 4;97(9):2532-40. doi: 10.1016/j.bpj.2009.08.011. Biophys J. 2009. PMID: 19883596 Free PMC article.
-
Potential of carbohydrate-binding agents as therapeutics against enveloped viruses.Med Res Rev. 2012 Mar;32(2):349-87. doi: 10.1002/med.20216. Epub 2010 Jun 23. Med Res Rev. 2012. PMID: 20577974 Free PMC article. Review.
-
Carbohydrate biomarkers for future disease detection and treatment.Sci China Chem. 2010;53(1):3-20. doi: 10.1007/s11426-010-0021-3. Epub 2010 Feb 7. Sci China Chem. 2010. PMID: 32214994 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical